🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 05280R100
- Market Cap
- Small Cap
- IPO
- 6/22/2018 · $17.00/share
- ADR Ratio
- 1:1
Business: Autolus Therapeutics plc is a clinical-stage biopharmaceutical company developing next-generation, programmed T cell therapies for the treatment of cancer. Using a broad suite of proprietary and modular T cell programming technologies, the company is engineering precisely targeted, controlled and highly active T cell therapies that are designed to better recognise cancer cells, break down their defence mechanisms and eliminate these cells.
Company Contact
- CEO
- Christian Itin
- PFO
- Dominic Moreland
- Investor Relations
- Susan A Noonan, S.A. Noonan Communications, LLC · 212-966-3650 · susan@sanoonan.com